|
AU2008201811A1
|
|
Multi-substituted selective androgen receptor modulators and methods of use thereof
|
|
AU2007202615A1
|
|
LPA receptor agonists and antagonists and methods of use
|
|
AU2006225325A1
|
|
Recombinant Rhabdovirus containing a heterologous fusion protein
|
|
CA2501867A1
|
|
Heterocyclic selective androgen receptor modulators and methods of use thereof
|
|
AU2003253780A1
|
|
TCELL TOLERANCE AND MODULATION OF AUTOIMMUNITY BY CD8Alpha-CD4+ DENDRITIC CELLS
|
|
US2003186918A1
|
|
Increasing growth factor production by cells
|
|
TW200413282A
|
|
Haloacetamide and azide substituted compounds and methods of use thereof
|
|
AU2003214971A1
|
|
Irreversible selective androgen receptor modulators and methods of use thereof
|
|
AU2003217304A8
|
|
Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy
|
|
CN1700923A
|
|
Multi-substituted selective androgen receptor modulators and methods of use thereof
|
|
WO03059621A1
|
|
Biodegradable cotton composites
|
|
US2010167377A1
|
|
Recombinant viruses comprising the membrane-proximal domain of VSV G protein
|
|
AU2002366710A8
|
|
Use of cpg oligodeoxynucleotides to induce angiogenesis
|
|
AU2002361642A8
|
|
Recombinant antibody fusion proteins and methods for detection of apoptotic cells
|
|
US2003157122A1
|
|
Streptococcal streptolysin S vaccines
|
|
WO03024402A2
|
|
Lpa receptor agonists and antagonists and methods of use
|
|
AU2002330019A1
|
|
Variants of corticotropin releasing hormone receptor type 1 and uses thereof
|
|
US6660962B2
|
|
Method for gas assisted energy beam engraving of a target object
|
|
WO02076399A2
|
|
YOHIMBINE DIMERS EXHIBITING BINDING SELECTIVITES FOR α2 ADRENERGIC RECEPTORS
|
|
WO02061391A2
|
|
Methods for detecting interaction of molecules with surface-bound reagents
|
